Skip to main content

Year: 2019

IBC Advanced Alloys Announces Closing of its C$2M Non-Brokered Private Placement; Announces Additional C$284,000 Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR FOR DISSEMINATION IN THE UNITED STATESFRANKLIN, Ind., Dec. 13, 2019 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) is pleased to announce that it has closed the Company’s previously announced non-brokered private placement (the “Offering”).

Continue reading

Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk

VASCEPA becomes the first and only FDA-approved medication for reducing cardiovascular risk beyond cholesterol lowering therapy in high-risk patients approved for treatmentMillions of people in the United States qualify as treatment candidates for VASCEPACardiovascular disease events, including heart attack, stroke and cardiovascular death, occur in the United States every 14 seconds and are economically, physically and emotionally costly VASCEPA has been assessed by independent bodies as priced cost effectively as a cardiovascular risk reduction treatment VASCEPA total net revenue guidance increased for 2019 to a range of $410 to $425 million and for 2020 is newly guided to a projected range of $650 to$700 millionAmarin to host webcast on Monday, December 16 at 7:30 a.m., Eastern TimeDUBLIN, Ireland and BRIDGEWATER, N.J., Dec. 13, 2019...

Continue reading

North American Financial 15 Split Corp. Class A Share Consolidation

TORONTO, Dec. 13, 2019 (GLOBE NEWSWIRE) — North American Financial 15 Split Corp. (the “Company”) announces a Class A share consolidation. In connection with the extension of the termination date of the Company, a special retraction right was offered allowing existing shareholders to tender one or both classes of shares and receive a retraction price based on the November 29, 2019 net asset value per unit.  In aggregate, more Preferred shares were tendered for retraction than Class A shares.  The purpose of the share consolidation is to maintain the requirement that an equal number of Class A shares and Preferred shares remain outstanding. Immediately after the special retraction payment on or before December 16, 2019, there will be 16,552,263 Preferred shares and 18,761,656 Class A shares outstanding.  In order to restore an equal...

Continue reading

Methode Electronics, Inc. Adds OhioHealth Retired CEO David Blom and Marmon Chairman and CEO Angelo Pantaleo to its Board of Directors

CHICAGO, Dec. 13, 2019 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application specific products and solutions, announced today the election of David Blom and Angelo Pantaleo as directors of the Company.Chairman Walter J. Aspatore said, “We are pleased to welcome David and Angelo to our board of directors and look forward to leveraging their extensive experience as CEOs and directors. David is an experienced healthcare administration executive who understands the complexity and trends of the healthcare delivery environment and will bring additional valuable insight to assist Methode in driving value creation with our Dabir Surface (medical device) offering. Angelo brings a wealth of expertise and will be a tremendous asset in supporting Methode’s focus on growing its industrial...

Continue reading

Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

RADNOR, Pa., Dec. 13, 2019 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that the Board of Directors of Marinus granted non-qualified stock options to purchase an aggregate of 121,000 shares of its common stock to new employees, with a grant date of December 11, 2019.The options have an exercise price of $1.78 per share, which is equal to the closing price of Marinus’s common stock on December 11, 2019, the date of grant. The options will vest and become exercisable as to 25 percent of the shares on the one-year anniversary of the recipient’s start date, and will vest and become exercisable as to the remaining 75 percent of the shares...

Continue reading

Concrete Leveling Systems, Inc. Provides Corporate Update

CANTON, Ohio, Dec. 13, 2019 (GLOBE NEWSWIRE) — Concrete Leveling Systems, Inc. (OTC PINK: CLEV) (the Company) and Jericho Associates, Inc. (Jericho), its gaming and hospitality division, are pleased to advise its Shareholders of the following.Concrete Leveling Systems, Inc. (CLEV – OTC) is pleased to disclose that its casino gaming and hospitality division, Jericho Associates, Inc. (Jericho) with its partners and associates (the “Partnership”) has entered into a formal binding Term Sheet with a California Tribe to design, build, and operate a new casino gaming and hotel resort on a major highway location. The comprehensive Term Sheet designates the Partnership to be its Development Partner and gives it the right to a seven (7) year management contract, earning a share of the net profits, or to be its slot machine vendor whereby...

Continue reading

Host Hotels & Resorts, Inc. Announces Fourth Quarter Dividend and Special Dividend on Common Stock

BETHESDA, Md., Dec. 13, 2019 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NYSE: HST), the nation’s largest lodging real estate investment trust, today announced that its board of directors authorized a regular quarterly cash dividend of $0.20 per share and a special dividend of $0.05 per share, bringing the total dividends declared for the year to $0.85 per share.  The dividend is payable on January 15, 2020, to stockholders of record on December 31, 2019. About Host Hotels & ResortsHost Hotels & Resorts, Inc. is an S&P 500 company and is the largest lodging real estate investment trust and one of the largest owners of luxury and upper-upscale hotels. The Company currently owns 75 properties in the United States and five properties internationally totaling approximately 46,600 rooms. The Company also holds...

Continue reading

Globus Medical Announces Board of Director Addition and Departure

AUDUBON, Pa., Dec. 13, 2019 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company’s Board of Directors, and the departure of Board member Kurt Wheeler, effective December 11, 2019.   Mr. Wheeler has assumed a role that precludes him from serving on public company Boards. Mr. Douglas has nearly thirty years of experience in medical device technology, with particular expertise in digital health.  Currently Mr. Douglas serves as the President and Chief Operating Officer in the Office of the CEO for ResMed, Inc. (NYSE:RMD, ASX:RMD), a medical device and software applications company specializing in cloud-connected devices that diagnose, treat and manage respiratory disorders and improve care in out-of-hospital settings.  Mr....

Continue reading

American Overseas Group Limited Announces Dividend on its Class B Preference Shares

HAMILTON, Bermuda, Dec. 13, 2019 (GLOBE NEWSWIRE) — American Overseas Group Limited (BSX:AORE.BH) (Pink Sheets: AOREF.PK) (“AOG” or the “Company”) today announced that the Board of Directors of its operating subsidiary, American Overseas Reinsurance Company Limited (“AORE”), declared a dividend on its Class B preference shares of $1,569.00 per Class B preference share.  The dividend will be payable on December 16, 2019 to Class B preference shareholders of record on December 9, 2019.   Information About the CompanyAmerican Overseas Group Limited is an insurance holding company incorporated in Bermuda and a tax resident of the United Kingdom.  Its operating subsidiaries provide specialty property/casualty insurance, reinsurance and insurance management services.  More information can be found at www.aoreltd.comSOURCE: American Overseas...

Continue reading

Freddie Mac Announces Pricing of $413 Million Multifamily Small Balance Loan Securitization

MCLEAN, Va., Dec. 13, 2019 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) announces the pricing of the SB69 offering, a multifamily mortgage-backed securitization backed by small balance loans underwritten by Freddie Mac and issued by a third-party trust. The company expects to guarantee approximately $413 million in Multifamily SB Certificates (SB69 Certificates), which are anticipated to settle on or about December 20, 2019. Freddie Mac Small Balance Loans generally range from $1 million to $6 million and are generally backed by properties with five or more units. This is the twelfth SB Certificate transaction in 2019.SB69 PricingDetails:Co-Lead Managers and Joint Bookrunners: J.P. Morgan Securities LLC and Wells Fargo Securities, LLCCo-Managers: FHN Financial Capital Markets, Mischler Financial Group, Inc., Stifel, Nicolaus &...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.